Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 1st Quarter

20 Feb 2020 11:00

RNS Number : 6207D
Income & Growth VCT (The) PLC
20 February 2020
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2019

 

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 December 2019. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 31 December 2019

At 30 September 2019

Net assets attributable to shareholders

£78,706,606

£81,728,079

Shares in issue

102,849,911

103,302,857

Net asset value (NAV) per share

76.53p

79.12p

Cumulative dividends paid to date per share since inception

117.50p

113.00p

Total return per share since inception (NAV basis)

194.03p

192.12p

Shareholders should note the NAV per share as at 31 December 2019 above does not include the impact of the two disposals that have occurred after the quarter end, as reported at the end of this Statement. If so, in isolation to any other factors that could affect it, the NAV per share above would increase by 1.93p.

 

CHANGE OF DIRECTORS

 

On 18 October 2019, the Company announced that, due to personal circumstances, Colin Hook was stepping down from his role as Chairman of the Board and as a director of the Company with immediate effect. The Company announced the appointment of Jonathan Cartwright, then an Independent Non-Executive Director and Chairman of the Audit Committee and Nomination and Remuneration Committee, as Chairman of the Board with immediate effect.

 

On 12 November 2019, the Company announced the appointment of Justin Ward as a Non-Executive Director of the Company. The Board appointed Justin as Chairman of both the Audit Committee and the Nomination and Remuneration Committee with immediate effect, succeeding Jonathan Cartwright in these two roles. Jonathan retained his membership of both committees.

 

On 12 February 2020, the Board announced the appointment of Maurice Helfgott as a Director and Chairman designate of the Company following Jonathan Cartwright's advice that he intends to step down as a Director and Chairman on 30 June 2020. Maurice will be appointed Chairman on 1 July 2020.

 

 

FUNDRAISING

 

On 25 October 2019, the Company launched an Offer for Subscription ("Offer") to raise, up to £5 million, with an over-allotment facility to raise up to a further £5 million. Following strong demand from investors, the Directors approved the use of the over-allotment facility on 14 December 2019. The Offer became fully subscribed on 20 December 2019 and, following the allotment of 12,939,834 new Ordinary shares on 8 January 2020, which generated net funds of £9.66 million for the Company, the Offer was formally closed.

 

DIVIDENDS

 

On 18 October 2019, the Company paid a second interim dividend of 4.50 pence per share in respect of the year ended 30 September 2019, to Shareholders on the register on 27 September 2019.

 

SHARE BUY-BACKS

 

On 13 December 2019, the Company bought back 452,946 of its Ordinary shares at a price of 70.75 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

INVESTMENT ACTIVITY

 

New investments

On 1 November 2019, the Company made a new investment of £1.54 million into Data Discovery Solutions Limited (trading as Active Navigation), a provider of enterprise-level file analysis software.

 

On 29 November 2019, the Company made a new investment of £0.96 million into IPV Limited, a developer of media asset management software.

 

On 13 December 2019, the Company made a new investment of £0.72 million into Bleach London Holdings Limited, an established and trusted brand in the hair colourants market.

 

Divestments

On 12 December 2019, the Company sold its investment in Redline Worldwide Limited, generating cash proceeds of £1.43 million. The realisation contributed, to date, to a return over the life of the investment of 1.6 times original cost. Deferred consideration of up to £0.26 million may be received over the next 30 months.

 

Divestments after the quarter end

On 7 February 2020, the Company's investment in Pattern Analytics Limited (trading as Biosite) was sold for proceeds of £2.65 million. Over the three years that this investment was held, these proceeds contributed to a multiple on cost of 1.5 times the original cost of investment. This realisation has had no material impact on the NAV per share as reported above.

 

On 13 February 2020, the Company sold its investment in Turner Topco Limited (trading as Auction Technology Group), generating cash proceeds of £5.27 million which, combined with returns received prior to a secondary buyout in June 2014, contributed to a multiple on original cost of 4.5 times over the 11 and a half years the investment was held. In isolation, the impact of this sale on the Company's NAV per share referred to above of 76.53p, would be an increase of 1.93p.

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

Please note that all of the information above is unaudited.

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCURVRRRNUUUAR
Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20253:49 pmRNSDirector/PDMR Shareholding
11th Apr 20253:12 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
6th Mar 20251:23 pmRNSInterim Management Statement
5th Mar 20256:05 pmRNSResult of AGM
5th Mar 20255:17 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20256:10 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20257:00 amRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
29th Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20243:10 pmRNSDirector/PDMR Shareholding
18th Oct 20242:58 pmRNSIssue of Equity and Total Voting Rights
17th Oct 20244:26 pmRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:05 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
26th Sep 20242:23 pmRNSTransaction in Own Shares and Total Voting Rights
18th Sep 202410:00 amRNSOffer for Subscription – Update
12th Sep 20245:31 pmRNSInterim Management Statement
11th Sep 20244:33 pmRNSDividend Declaration
2nd Sep 20243:15 pmRNSOffers for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:30 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:35 amRNSTotal Voting Rights
27th Jun 20248:00 amRNSDirector Declaration
18th Jun 20245:54 pmRNSPROPOSED MERGER AND OFFERS
12th Jun 20244:08 pmRNSHalf-year Report
12th Jun 202410:39 amRNSIssue of Equity and Total Voting Rights
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
7th Jun 202411:05 amRNSDirector/PDMR Shareholding
7th Jun 202410:29 amRNSIssue of Equity and Total Voting Rights
3rd Jun 20242:29 pmRNSNet Asset Value at 31 March 2024
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.